Speakers 2012

Day One – February, 6

Naira Adamian,
Director General, Janssen-Cilag Russia

Ivan Anokhin,
Marketing Director, Akrihin

Sergey Beloborodov,
Director, Prescription drugs Business Unit, Teva Russia

Ivan Blanarik,
CEO, Boehringer Ingelheim

Vladimir Boyko,
CCO, Novartis Consumer Health

Illarion Boyko,
CCO, NYCOMED: a Takeda Company

Igor Goryanin,
Head of biologic and medical technology cluster, Innovation Centre Skolkovo

Nikolay Demidov,
CEO, Pharmexpert

Maria Denisova,
Executive Director, IMS-Health Russia

Victor Dmitriev,
CEO, ARPM

Nikolay Zhavoronkov,
Deputy Director for marketing and strategic planning, Jadran

Stephane Crespel,
CEO, Boiron

Sergey Tsyb,
Director of Chemical-Engineering Complex and Bioengineering Technology Department, Ministry of Economic Development of the Russian Federation

Maria Izmestieva,
Marketing Director Rx Business Unit, TEVA Russia

Herman Inozemtsev,
Strategy & Business Development, Director, MBA, Synovate Comcon Healthcare Russia

Inna Kasparova, PhD
Business Development Manager, Pfizer HCP Corporation, Russia

Igor Klimanov,
Marketing Director, Petrovax

Alexey Krivoshapko,
Director, Prosperity Capital Management

Alexander Kuzin,
Deputy Director General, Pharmacy chain Rigla

Yuriy Litvishcenko,
CEO, Chiesi Pharmaceuticals, Deputy Head, Committee for Healthcare and Pharmaceuticals, Association of European Businesses in Russia

David Melek-Guseinov,
CEO, Cegedim Strategic Data, Chairman of the Expert Board for healthcare, Delovaya Rossiya

Nikola Milevcic,
Head of Rep. Office in Russia, Grifols, Inc

Rustem Muratov,
Vice President for Development, Rosta Group

Timofey Nizhegorodtsev,
Head of Directorate of social sphere and trade control, FAS

Timofey Petrov,
CEO, Pharm-Sintez

Vitaliy Smerdov,
CEO, Sotex

Valeria Solok,
CEO, MC 36.6

Igor Filatov,
CEO, Protek

Henry Fogels,
Head of Business Division in Russia, Oriola-KD (Distribution company Oriola, pharmacy chains Stary Lekar, Apteka 03)

Vladimir Shipkov,
Executive Director, AIPM

Dmitry Shchurov,
Director of strategic business planning, Pfizer H.C.P. Corporation

Marina Veldanova,
Head of Rep. Office Russia, Ipsen Pharma

Day Two – February, 7

Julia Velikanova,
Legal Department Director, STADA CIS

Elena Gankina,
Director of registration and quality Department, Bristol-Myers Squibb

Sergey Puzyrevskiy,
Head of Legal Directorate, Federal Antimonopoly Service

Anatoly Semenov,
Deputy Chairman, "Monopolizmu.net"

Natalia Totakhevage,
Director for collaboration with strategic partners, Lifescan, Russia, CIS, Central and Eastern Europe, Johnson & Johnson

Valentina Fedorova,
the former Head of Intellectual Property Office, Scientific Research and Development Complex, Binnofarm